EUVIMEDEUVIMED entdecken
Open Access

Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparity

Motoko Koyama, Daniel S Hippe, Sujatha Srinivasan, Sean C Proll, Oriana Miltiadous, Naisi Li, Ping Zhang, Kathleen S Ensbey, Noah G Hoffman, Christine R Schmidt, Albert C Yeh, Simone A Minnie und 14 weitere

Immunity · 2023-08 · 56 (8) · 1876-1893.e8

DOI: 10.1016/j.immuni.2023.06.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, 2023-08. Verfasst von Motoko Koyama und 25 weiteren Autor:innen. Beteiligte Einrichtung: Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA. Electronic address: mkoyama@fredhutch.…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute graft-versus-host disease (aGVHD) remains a major limitation of allogeneic stem cell transplantation (SCT), and severe intestinal manifestation is the major cause of early mortality. Intestinal microbiota control MHC class II (MHC-II) expression by ileal intestinal epithelial cells (IECs) that promote GVHD. Here, we demonstrated that genetically identical mice of differing vendor origins had markedly different intestinal microbiota and ileal MHC-II expression, resulting in discordant GVHD severity. We utilized cohousing and antibiotic treatment to characterize the bacterial taxa positively and negatively associated with MHC-II expression. A large proportion of bacterial MHC-II inducers were vancomycin sensitive, and peri-transplant oral vancomycin administration attenuated CD4+ T cell-mediated GVHD. We identified a similar relationship between pre-transplant microbes, HLA class II expression, and both GVHD and mortality in a large clinical SCT cohort. These data highlight therapeutically tractable mechanisms by which pre-transplant microbial taxa contribute to GVHD independently of genetic disparity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeGraft vs Host DiseaseHematopoietic Stem Cell TransplantationMiceAnimalsVancomycinTransplantation, Homologous

Stichwörter der Autor:innen

GVHDMHC class II antigen presentationantibioticsgraft-versus-host diseaseinterferon-γintestinal epithelial cellsmicrobiota

Substanzen

Vancomycin

Autor:innen und Institutionen

  • Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA. Electronic address: mkoyama@fredhutch.org.
  • Clinical Research Division, FHCC, Seattle, WA 98109, USA.
  • Vaccine and Infectious Disease Division, FHCC, Seattle, WA 98109, USA.
  • Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center (FHCC), Seattle, WA 98109, USA.
  • Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.

Förderung

  • NCI NIH HHS
  • NHLBI NIH HHS
  • NIH HHS
  • NIA NIH HHS
  • National Heart, Lung, and Blood Institute
  • National Institute on Aging
  • Seres Therapeutics
  • Parker Institute for Cancer Immunotherapy

Zitieren

APA

Koyama, M., Hippe, D. S., Srinivasan, S., Proll, S. C., Miltiadous, O., Li, N., Zhang, P., Ensbey, K. S., Hoffman, N. G., Schmidt, C. R., Yeh, A. C., Minnie, S. A., Strenk, S. M., Fiedler, T. L., Hattangady, N., Kowalsky, J., Grady, W. M., Degli-Esposti, M. A., Varelias, A., …, & Hill, G. R. (2023). Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparity. Immunity, 56(8), 1876-1893.e8. https://doi.org/10.1016/j.immuni.2023.06.024

Vancouver

Koyama M, Hippe DS, Srinivasan S, Proll SC, Miltiadous O, Li N, et al. Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparity. Immunity. 2023;56(8):1876-1893.e8. doi:10.1016/j.immuni.2023.06.024

BibTeX
@article{Koyama2023,
  author = {Koyama, Motoko and Hippe, Daniel S and Srinivasan, Sujatha and Proll, Sean C and Miltiadous, Oriana and Li, Naisi and Zhang, Ping and Ensbey, Kathleen S and Hoffman, Noah G and Schmidt, Christine R and Yeh, Albert C and Minnie, Simone A and Strenk, Susan M and Fiedler, Tina L and Hattangady, Namita and Kowalsky, Jacob and Grady, Willian M and Degli-Esposti, Mariapia A and Varelias, Antiopi and Clouston, Andrew D and van den Brink, Marcel R M and Dey, Neelendu and Randolph, Timothy W and Markey, Kate A and Fredricks, David N and Hill, Geoffrey R},
  title = {Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparity},
  journal = {Immunity},
  year = {2023},
  volume = {56},
  number = {8},
  pages = {1876--1893.e8},
  doi = {10.1016/j.immuni.2023.06.024}
}
Kostenlos starten →